Related Experiment Video
Updated: Jul 15, 2025

11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.3K
Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three
Iain A Gillespie1, Eleanor Barnes2,3, Ian C K Wong4,5
1GSK, Gunnels Wood Road, Stevenage, SG1 2NY, Hertfordshire, UK. iain.a.gillespie@gsk.com.
Infectious Diseases and Therapy
|September 27, 2023
Abstract
No abstract available in PubMed .
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Chronic Pancreatitis II: Collaborative Care
108
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
108

